Publications, Pharmaceutical

Pre-filled syringes offer multiple benefits for COVID-19 vaccination

The pandemic has had a hugely disruptive impact on the vaccines market because of the unprecedented need to deliver effective COVID-19 vaccines in a highly accelerated timeframe. Aptar Pharma has worked at the forefront of this response, alongside those in academic research, and in the pharmaceutical and medical technology industries. This article introduces the company’s vaccine platform approach highlighting the advantages of pre-filled syringes which offer compelling benefits for large-scale vaccination programmes. COVID-19 vaccine manufacturers are routinely selecting Aptar Pharma’s PremiumCoat® technology which uses an ETFE coating in combination with a state-of-the-art bromobutyl formulation to minimize leachables and preserve vaccine quality.

Download Publication
Drug Development & Delivery
13 Sep 2021
Back To Top